UDK: 616-092
M.E. Statsenko, S.V. Turkina, M.N. Ustinova, A.V. Tumarenko, O.Yu. Sviridenko, A.O. Sviridenko
Волгоградский государственный медицинский университет, Волгоград, Россия
Non-alcoholic fatty liver disease (NAFLD) and hyperuricemia (HU) are currently considered by many authors as a manifestation of the metabolic syndrome (MS) and associated with insulin resistance (IR), increased body mass index (BMI), type 2 diabetes mellitus (DM2), cardiovascular disease (CVD). The latest data of numerous studies prove that HU is a significant risk factor for the development of not only obesity, DM2, CVD, but also NAFLD.
non-alcoholic fatty liver disease, hyperuricemia, type 2 diabetes mellitus, cardiovascular disease
Маргарита Николаевна Устинова, ustinovavolgmed@yandex.ru